Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adham Saad

Surgery Tampa, FL Medical Doctor

NPI 1154507754 CMS profile 1291705

2 Tampa General Cir, Tampa, FL 33606

Open in the dashboard

General payments

$166,575

245 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adham Saad of Tampa, FL is reported in the CMS Open Payments database as having received $166,575 across 245 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,986 71
2024 General $25,411 37
2023 General $40,683 59
2022 General $14,943 50
2021 General $14,239 16
2020 General $3,118 3
2019 General $3,194 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adham Saad
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Adham Saad were reported at $64,986. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Adham Saad Surgery median Middle half National median
2019 $3,194 $253 $82–$1,521 $163
2020 $3,118 $131 $40–$706 $114
2021 $14,239 $168 $50–$904 $132
2022 $14,943 $224 $76–$1,218 $149
2023 $40,683 $253 $82–$1,255 $160
2024 $25,411 $279 $90–$1,381 $164
2025 $64,986 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $104,946 114 payments
  2. Intuitive Surgical, Inc. $53,796 88 payments
  3. Medtronic, Inc. $2,874 16 payments
  4. CONMED Corporation $2,154 2 payments
  5. Covidien LP $575 1 payment
  6. Ethicon US, LLC $375 3 payments
  7. TELA Bio, Inc. $339 4 payments
  8. Solventum Corporation $319 5 payments
  9. Acera Surgical, Inc. $256 2 payments
  10. W. L. Gore & Associates, Inc. $237 2 payments
  11. Other $703 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $92,215 37 payments
  2. Education $34,500 11 payments
  3. Travel and Lodging $20,843 75 payments
  4. Food and Beverage $10,004 115 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,000 6 payments
  6. Gift $14 1 payment
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $84,265 91 payments
  2. OMNIGRAFT $77,131 66 payments
  3. Da Vinci Surgical System $53,796 88 payments
  4. Cytal Recon-Skin And Wound $9,900 2 payments
  5. CYTAL Recon-Skin And Wound $9,900 2 payments
  6. Integra Recon-Skin And Wound $9,839 54 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $7,339 52 payments
  8. DuraSorb Monofilament Mesh $5,903 4 payments
  9. Integra Recon-Skin And Wound $4,633 23 payments
  10. PRIMATRIX $4,633 23 payments
  11. Other $14,164 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$46,011

Medicare's payments for the services billed

Medicare patients

115

Average age 71

Services billed

196

66 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 36%
Chronic kidney disease 30%
Diabetes 28%
Depression 27%
Cancer 24%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

245 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record